{"database": "openregs", "table": "documents", "rows": [["FDA-2006-D-0356-0004", "FDA", "FDA-2006-D-0356", "Draft Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Availability; Reopening of Comment Period", "Notice", "NEC-Notice of Extension", "2008-09-11T04:00:00Z", 2008, 9, "2008-09-11T04:00:00Z", "2008-10-15T03:59:59Z", "2024-11-12T04:19:51Z", "E8-21197", 1, 0, "09000064806ff38c"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2006-D-0356-0004"], "units": {}, "query_ms": 105.38913600612432, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}